Latest & greatest articles for cetirizine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cetirizine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cetirizine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cetirizine

1. Cetirizine

Cetirizine Top results for cetirizine - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for cetirizine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. Cetirizine

Cetirizine USE OF CETIRIZINE IN PREGNANCY 0344 892 0909 USE OF CETIRIZINE IN PREGNANCY (Date of issue: November 2018 , Version: 3 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Cetirizine, the active metabolite of hydroxyzine, is a non-sedating (...) antihistamine used for the symptomatic relief of allergic conditions including rhinitis (hay fever) and chronic idiopathic urticaria. Studies which have investigated maternal cetirizine use in pregnancy do not provide evidence of an increased risk of congenital malformation, intrauterine growth restriction or preterm delivery. Whilst the majority of controlled studies investigating spontaneous abortion risks following maternal cetirizine use in pregnancy provide no evidence of an association, a single study

2014 UK Teratology Information Service

3. Chronic urticaria: off-label doses of cetirizine

Chronic urticaria: off-label doses of cetirizine Chronic urticaria: off-label doses of cetirizine Chronic urticaria: off-label doses of cetirizine Evidence summary Published: 8 July 2014 nice.org.uk/guidance/esuom31 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in July 2014. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up- to-date information. Summary (...) Overall, 2 small randomised controlled trials (RCTs) and 2 double-blind crossover studies (total n=76) suggest that cetirizine 20 mg daily may improve weals and itching in adults with severe chronic urticaria refractory to standard doses of antihistamines. However, symptoms remain in a proportion of people and the studies have many limitations. Nevertheless, cetirizine 20 mg appears to be well tolerated and the benefits may outweigh the risks for some people whose quality of life is significantly

2014 National Institute for Health and Clinical Excellence - Advice

4. Comparative Effect of Beclomethasone Dipropionate and Cetirizine on Acoustic Rhinometry Parameters in Children With Perennial Allergic Rhinitis: A Randomized Controlled Trial. Full Text available with Trip Pro

Comparative Effect of Beclomethasone Dipropionate and Cetirizine on Acoustic Rhinometry Parameters in Children With Perennial Allergic Rhinitis: A Randomized Controlled Trial. The effect of intranasal corticosteroids and oral antihistamines on acoustic rhinometry parameters has not been directly compared. The primary objective was to compare the effect of a 21-day course of treatment with nasal beclomethasone dipropionate (nBDP) with that of cetirizine (CTZ) on nasal patency measured using

2018 Journal of investigational allergology & clinical immunology Controlled trial quality: uncertain

5. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. (Abstract)

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Pharmacologic treatment is a mainstay of allergy therapy and many caregivers use over-the-counter antihistamines for the treatment of seasonal allergic rhinitis (SAR) symptoms in children.To assess the efficacy and safety of cetirizine 10 mg syrup versus loratadine 10 mg syrup versus placebo syrup in a randomized double-blind study of children, ages 6-11 years, with SAR.This randomized (...) , double-blind, parallel-group, placebo-controlled study was conducted at 71 U.S. centers during the spring tree and grass pollen season. After a 1-week placebo run-in period, qualified subjects were randomized to once-daily cetirizine 10 mg (n = 231), loratadine 10 mg (n = 221), and placebo (n = 231) for 2 weeks. The primary efficacy end point was change from baseline in the subject's mean reflective total symptom severity complex (TSSC) score over 14 days.Children treated with cetirizine experienced

2017 Allergy and Asthma Proceedings Controlled trial quality: predicted high

6. Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) - Full Text View - ClinicalTrials.gov Hide (...) glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal

2016 Clinical Trials

7. Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions. Full Text available with Trip Pro

Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions. 21945608 2011 12 12 2018 11 13 1097-6825 128 5 2011 Nov The Journal of allergy and clinical immunology J. Allergy Clin. Immunol. Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions. 1127-8 10.1016/j.jaci.2011.08.026 Park Joon H JH Godbold James H JH Chung Danna D Sampson Hugh A HA Wang Julie J eng RR026134 RR NCRR NIH HHS United States (...) Allergy Clin Immunol 1275002 0091-6749 0 Anti-Allergic Agents 0 Hypnotics and Sedatives 8GTS82S83M Diphenhydramine YO7261ME24 Cetirizine AIM IM Acute Disease Adolescent Anti-Allergic Agents therapeutic use Cetirizine therapeutic use Child Child, Preschool Diphenhydramine therapeutic use Food Hypersensitivity drug therapy Humans Hypnotics and Sedatives Young Adult 2011 03 30 2011 08 19 2011 08 31 2011 9 28 6 0 2011 9 29 6 0 2011 12 14 6 0 ppublish 21945608 S0091-6749(11)01392-3 10.1016/j.jaci

2011 The Journal of allergy and clinical immunology Controlled trial quality: uncertain

8. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. (Abstract)

A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. Androgenetic alopecia (AGA) is a common form of scalp hair loss that affects up to 50% of males between 18 and 40 years old. Several molecules are commonly used for the treatment of AGA, acting on different steps of its pathogenesis (Minoxidil, Finasteride, Serenoa repens) and show some side effects. In literature, on the basis of hypertrichosis observed in patients treated with analogues (...) of prostaglandin PGF2a, it was supposed that prostaglandins would have an important role in the hair growth: PGE and PGF2a play a positive role, while PGD2 a negative one.We carried out a pilot study to evaluate the efficacy of topical cetirizine versus placebo in patients with AGA.A sample of 85 patients was recruited, of which 67 were used to assess the effectiveness of the treatment with topical cetirizine, while 18 were control patients.We found that the main effect of cetirizine was an increase in total

2017 Journal of Dermatological Treatment Controlled trial quality: uncertain

9. Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets

Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets Drug Approval Package: Zyrtec Allergy (cetirizine) NDA #022578 Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets, 10 mg Company: McNeil Consumer Healthcare Application No.: 022578 Approval Date: 09/03/2010 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF

2011 FDA - Drug Approval Package

10. A multicentric trial of loratadine and cetirizine in urticaria. (Abstract)

A multicentric trial of loratadine and cetirizine in urticaria. Two hundred and ten patients with chronic urticaria were divided into two groups; one group was treated with Loratadine 10mg daily while the other with cetirizine 10mg daily. The total duration of treatment was four weeks. Pretreatment and post-treatment evaluations were made. It was noticed that loratadine was superior to cetirizine in terms of a rapid onset of actions, overall clinical efficacy and minimal side effects.

2012 Indian journal of dermatology, venereology and leprology Controlled trial quality: uncertain

11. Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. (Abstract)

Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. 1979473 1991 01 24 2013 11 21 0003-4738 65 6 1990 Dec Annals of allergy Ann Allergy Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. 504-8 Bousquet J J Services des Maladies Respiratoires, Centre Hospitalier Universitaire, Montpellier, France. Emonot A A Germouty J J Molina C C Montané F F Perrin-Fayolle M M Prud'homme A A Sabbah A A Taytard A A Dupont P P eng Clinical Trial Journal Article (...) Multicenter Study Randomized Controlled Trial United States Ann Allergy 0372346 0003-4738 0 Histamine H1 Antagonists 30S50YM8OG Hydroxyzine YO7261ME24 Cetirizine IM Adolescent Adult Aged Asthma drug therapy etiology Cetirizine Child Dose-Response Relationship, Drug Double-Blind Method Histamine H1 Antagonists therapeutic use Humans Hydroxyzine analogs & derivatives therapeutic use Middle Aged Poaceae Pollen 1990 12 1 1990 12 1 0 1 1990 12 1 0 0 ppublish 1979473

1991 Annals of Allergy Controlled trial quality: uncertain

12. Cetirizine effects on the cutaneous allergic reaction in humans. (Abstract)

Cetirizine effects on the cutaneous allergic reaction in humans. 1979475 1991 01 24 2013 11 21 0003-4738 65 6 1990 Dec Annals of allergy Ann Allergy Cetirizine effects on the cutaneous allergic reaction in humans. 512-6 Michel L L INSERM U 312, Service de Dermatologie, Hôpital Henri Mondor, Creteil, France. De Vos C C Dubertret L L eng Clinical Trial Journal Article Randomized Controlled Trial United States Ann Allergy 0372346 0003-4738 0 Allergens 0 Histamine H1 Antagonists 30S50YM8OG (...) Hydroxyzine 820484N8I3 Histamine YO7261ME24 Cetirizine IM Adult Allergens pharmacology Cetirizine Dermatitis, Atopic drug therapy Double-Blind Method Female Histamine pharmacology Histamine H1 Antagonists therapeutic use Humans Hydroxyzine analogs & derivatives therapeutic use Male Skin drug effects Skin Physiological Phenomena 1990 12 1 1990 12 1 0 1 1990 12 1 0 0 ppublish 1979475

1991 Annals of Allergy Controlled trial quality: uncertain

13. Therapeutic effects of cetirizine in delayed pressure urticaria. Part 1. Effects on weight tests and skin-window cytology. (Abstract)

Therapeutic effects of cetirizine in delayed pressure urticaria. Part 1. Effects on weight tests and skin-window cytology. 1979476 1991 01 24 2013 11 21 0003-4738 65 6 1990 Dec Annals of allergy Ann Allergy Therapeutic effects of cetirizine in delayed pressure urticaria. Part 1. Effects on weight tests and skin-window cytology. 517-9 Kontou-Fili K K Section of Allergology, Laikon General Hospital, Athens, Greece. Maniatakou G G Demaka P P Gonianakis M M Paleologos G G eng Clinical Trial Journal (...) Article Randomized Controlled Trial United States Ann Allergy 0372346 0003-4738 0 Histamine H1 Antagonists 30S50YM8OG Hydroxyzine YO7261ME24 Cetirizine IM Adult Aged Cetirizine Double-Blind Method Female Histamine H1 Antagonists therapeutic use Humans Hydroxyzine analogs & derivatives therapeutic use Male Middle Aged Pressure adverse effects Skin cytology drug effects Skin Physiological Phenomena Skin Window Technique Time Factors Urticaria drug therapy etiology physiopathology 1990 12 1 1990 12 1 0 1

1991 Annals of Allergy Controlled trial quality: uncertain

14. Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. (Abstract)

Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. 1979471 1991 01 24 2013 11 21 0003-4738 65 6 1990 Dec Annals of allergy Ann Allergy Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. 498-500 Kietzmann H H Department of Dermatology, University of Kiel, Germany. Macher E E Rihoux J P JP Ghys L L eng Clinical Trial Comparative Study Journal Article Multicenter Study Randomized Controlled Trial United States Ann (...) Allergy 0372346 0003-4738 0 Benzhydryl Compounds 0 Histamine H1 Antagonists 30S50YM8OG Hydroxyzine 7BA5G9Y06Q Terfenadine YO7261ME24 Cetirizine IM Benzhydryl Compounds therapeutic use Cetirizine Chronic Disease Double-Blind Method Histamine H1 Antagonists therapeutic use Humans Hydroxyzine analogs & derivatives therapeutic use Terfenadine Urticaria drug therapy 1990 12 1 1990 12 1 0 1 1990 12 1 0 0 ppublish 1979471

1991 Annals of Allergy Controlled trial quality: uncertain

15. Comparative Study of Apo-Cetirizine Single Therapy and Intermittent Sequential Therapy with Cetirizine, Loratadine and Chlorpheniramine in Allergic Rhinitis. Full Text available with Trip Pro

Comparative Study of Apo-Cetirizine Single Therapy and Intermittent Sequential Therapy with Cetirizine, Loratadine and Chlorpheniramine in Allergic Rhinitis. There are limited numbers of articles, studying combined use of antihistamines. In this study, we compare single therapy of Apo-Cetirizine with a new regimen of intermittent sequential therapy with cetirizine, loratadine and chlorpheniramine in treatment of seasonal allergic rhinitis. This randomized clinical trial was performed between (...) April and September at the peak prevalence of seasonal allergic rhinitis. Fifty-four eligible patients diagnosed clinically to have seasonal allergic rhinitis were randomized in two groups: 24 cases in single therapy arm, received Apo-Cetirizine 10 mg tablet daily and in other arm, 30 patients received sequential regimen of cetirizine 10 mg tablet, loratadine 10 mg tablet and chlorpheniramine 4 mg tablet, one tablet each day. Major Symptom Complex Score (MSCS) and Total Symptom Complex Score (TSCS

2016 Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India Controlled trial quality: uncertain

16. A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01916226 Recruitment Status

2013 Clinical Trials

17. Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study. (Abstract)

Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study. Allergic cutaneous challenge causes mast cell and basophil mediator release which recruit inflammatory cells to the site of antigen administration. This secondary cell infiltration and mediator release is responsible for the changes seen during the late phase of allergic diseases. In this randomised, double-blind, cross-over, placebo controlled study (...) , it was demonstrated that, at steady-state drug concentrations, chlorpheniramine reduced the wheal-and-flare reaction by about 50% compared to the 75% reduction, on average, by cetirizine and ketotifen. Cetirizine significantly reduced eosinophil vacuolisation at all observation periods, i.e. 2,6,10 and 24 h, and also inhibited basophil accumulation significantly at 10 h (75% reduction), while chlorpheniramine had a negligible effect on these variables. These changes would indicate that the late phase reaction

1992 European journal of clinical pharmacology Controlled trial quality: uncertain

18. A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis. Full Text available with Trip Pro

A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis. Azelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action (...) of azelastine nasal spray, versus the oral antihistamines loratadine 10 mg and cetirizine 10 mg in the relief of the symptoms of SAR.70 participants, aged 18-65, were randomized to receive azelastine nasal spray, cetirizine, loratadine, or placebo after controlled ragweed pollen exposure in the EEU. Symptoms were evaluated using the total nasal symptom score (TNSS). The primary efficacy parameter was the onset of action as measured by the change from baseline in TNSS.Azelastine displayed a statistically

2013 Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology Controlled trial quality: predicted high

19. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. (Abstract)

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. Fexofenadine hydrochloride (HCl) is a new H(1) antihistamine used twice daily in some countries.A multicenter, double-blind, parallel-group, placebo-controlled trial compared the efficacy and safety of fexofenadine HCl (120 and 180 mg administered once daily) and cetirizine (10 mg once daily) in the treatment of seasonal (...) allergic rhinitis.After a 3- to 5-day run-in period, patients meeting entrance criteria were randomized to receive placebo, fexofenadine HCl 120 mg once daily, fexofenadine HCl 180 mg once daily, or cetirizine 10 mg once daily (active control) for 2 weeks. Eight hundred twenty-one patients comprised the intention-to-treat population and 722 patients completed the study. Symptom assessments were conducted 12 hours after the dose for the previous 12 hours and again at 24 hours after the dose

1999 The Journal of allergy and clinical immunology Controlled trial quality: predicted high

20. The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. (Abstract)

The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. This double-blind cross-over study compared the potential of bilastine, cetirizine, and fexofenadine to relieve the symptoms of allergic rhinitis.Seventy-five allergic volunteers were challenged with grass pollen in the Vienna Challenge Chamber (VCC) on two consecutive days of allergen provocation; 6 h (...) on day 1 and 4 h day 2. Bilastine 20 mg, cetirizine 10 mg, fexofenadine 120 mg, or placebo were taken orally 2 h after the start of provocation on day 1 only. Total nasal symptom scores, the global symptom scores, nasal secretions, and eye symptoms were assessed on both day 1 and day 2.Bilastine had a rapid onset of action, within 1 h, and a long duration of action, greater than 26 h. Cetirizine was similar. Fexofenadine was similar on day 1 but less effective on day 2, indicating a shorter duration

2010 Inflammation research : official journal of the European Histamine Research Society ... [et al.] Controlled trial quality: uncertain